0000882104-20-000183.txt : 20201119 0000882104-20-000183.hdr.sgml : 20201119 20201119173324 ACCESSION NUMBER: 0000882104-20-000183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201119 DATE AS OF CHANGE: 20201119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 201329765 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 wf-form4_160582519028728.xml FORM 4 X0306 4 2020-11-17 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001202335 GRYSKA DAVID W 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 1 0 0 0 Common stock 2020-11-17 4 S 0 100000 2.40 D 145337 D Common stock 2020-11-18 4 S 0 50000 2.39 D 95337 D /s/ Nathan N. Kryszak, Attorney-in-Fact for David W. Gryska 2020-11-18